Invesco
DMTK

Invesco’s DermTech, Inc. Common Stock DMTK Stock Holding History

Invesco’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,458
Closed -$400K – 4118
2021
Q3 		$400K Buy
12,458
+2,752
+28% +$96.7K ﹤0.01% 3528
2021
Q2 		$403K Buy
9,706
+3,810
+65% +$157K ﹤0.01% 3508
2021
Q1 		$299K Buy
+5,896
New +$308K ﹤0.01% 3552

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco's DMTK Position: Q4 2021 in Review

Invesco sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 12,458 shares — an estimated $400K sold.

Invesco first reported a position in DMTK in Q1 2021 and held it in 3 quarters. The position peaked at $403K in Q2 2021. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

  • Invesco reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Invesco sold 12,458 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $400K.
  • Invesco first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Invesco's DermTech, Inc. Common Stock position peaked at $403K in Q2 2021.
  • 143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.